n-desmethylclobazam has been researched along with Body Weight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishitsu, T; Kaneko, S; Nagata, R; Nakagawa, K; Nakashima, H; Nishimura, M; Ogusu, N; Saruwatari, J; Seo, T; Shimomasuda, M; Tanikawa, K; Tsuda, Y; Yasui-Furukori, N | 1 |
Chhun, S; Chiron, C; Dulac, O; Jullien, V; Pons, G; Rey, E; Tod, M | 1 |
2 other study(ies) available for n-desmethylclobazam and Body Weight
Article | Year |
---|---|
Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Body Weight; Child; Child, Preschool; Clobazam; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Epilepsy; Female; Gene Frequency; Humans; Infant; Japan; Male; Metabolic Clearance Rate; Middle Aged; NADPH-Ferrihemoprotein Reductase; Polymorphism, Genetic; Retrospective Studies; Sex Factors | 2014 |
Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
Topics: Anticonvulsants; Benzodiazepines; Body Weight; Child; Child, Preschool; Clobazam; Dioxolanes; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Female; Humans; Male; Prospective Studies; Randomized Controlled Trials as Topic; Valproic Acid | 2015 |